PCM
ACLX

Pathway Capital Management’s Arcellx ACLX Stock Holding History

Pathway Capital Management’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-51,051
Closed -$4.19M – 6
2025
Q3 		$4.19M Buy
+51,051
New +$3.68M 20.6% 2
2023
Q1 		– Sell
-189,120
Closed -$5.86M – 5
2022
Q4 		$5.86M Buy
+189,120
New +$4.34M 10.46% 3

Other funds holding ACLX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pathway Capital Management's ACLX Position: Q4 2025 in Review

Pathway Capital Management sold out of Arcellx (ACLX) in Q4 2025, closing a stake of 51,051 shares — an estimated $4.19M sold.

Pathway Capital Management first reported a position in ACLX in Q4 2022 and held it in 2 quarters. The position peaked at $5.86M in Q4 2022. 218 funds tracked by Wall St. Rank hold ACLX as of Q4 2025.

  • Pathway Capital Management reported no remaining Arcellx position as of Q4 2025 after selling out during the quarter.
  • Pathway Capital Management sold 51,051 Arcellx shares in Q4 2025, an estimated $4.19M.
  • Pathway Capital Management first reported a position in Arcellx in Q4 2022 and held it in 2 quarters.
  • Pathway Capital Management's Arcellx position peaked at $5.86M in Q4 2022.
  • 218 funds tracked by Wall St. Rank held Arcellx as of Q4 2025.

Based on Pathway Capital Management's 13F filing for Q4 2025, filed 4 Feb 2026.